Kainic acid induced expression of interleukin-1 receptor antagonist mRNA in the rat brain

Molecular Brain Research

Volumn 58, Issue 1-2, 1998, Pages 195-208

  Eriksson, Charlotta ^a   Winblad, Bengt ^a   Schultzberg, Marianne ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cytokine; ED1; Glutamate receptor; In situ hybridization histochemistry; Microglia; Neurodegeneration

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; KAINIC ACID; MESSENGER RNA;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; BRAIN NERVE CELL; CONTROLLED STUDY; ENTORHINAL CORTEX; GENE INDUCTION; HIPPOCAMPUS; HISTOCHEMISTRY; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MICROGLIA; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; PYRIFORM CORTEX; RAT; TEMPORAL CORTEX; THALAMUS;

ANIMALS; BRAIN; IN SITU HYBRIDIZATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; KAINIC ACID; MALE; ORGAN SPECIFICITY; RATS; RATS, SPRAGUE-DAWLEY; RNA PROBES; RNA, MESSENGER; SIALOGLYCOPROTEINS; TRANSCRIPTION, GENETIC;

EID: 0032528102     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00125-9     Document Type: Article

References (78)

1. J. Andersson, L. Björk, C.A. Dinarello, H. Towbin, A. Andersson, Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell, Eur. J. Immunol. 22 (1992) 2617-2623.
2. P.B. Andersson, V.H. Perry, S. Gordon, The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration, Neuroscience 42 (1991) 201-214.
3. W.P. Arend, Interleukin-1 receptor antagonist, Adv. Immunol. 54 (1993) 167-227.
4. E. Ban, F. Haour, R. Lenstra, Brain interleukin 1 gene expression induced by lipopolysaccharide administration, Cytokine 4 (1992) 48-54.
5. R. Bertini, M. Sirone, I. Martin-Padura, F. Colotta, A. Rambaldi, S. Bernasconi, P. Ghezzi, S.J. Haskill, P. Ralph, D. Liu, A. Mantovani, Inhibitory effect of recombinant intracellular interleukin 1 receptor antagonist on endothelial cell activation, Cytokine 4 (1992) 44-47.
6. H. Besedovsky, A. Del Rey, E. Sorkin, C.A. Dinarello, Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones, Science 233 (1986) 652-654.
7. M.P. Bevilacqua, J.S. Pober, M.E. Wheele, R.S. Cotran, M.A. Gimbrone, Interleukin-1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines, J. Clin. Invest. 76 (1985) 2003-2011.
8. C.F. Bigler, D.A. Norris, W.L. Weston, W.P. Arend, Interleukin-1 receptor antagonist production by human keratinocytes, J. Invest. Dermatol. 98 (1992) 38-44.
9. C. Butcher, A. Steinkasserer, S. Tejura, A.C. Lennard, Comparison of two promoters controlling expression of secreted or intracellular IL-1 receptor antagonist, J. Immunol. 153 (1994) 701-711.
10. M. Buttini, H. Boddeke, Peripheral lipopolysaccharide stimulation induces interleukin-1β messenger RNA in rat brain microglial cells, Neuroscience 65 (1995) 523-530.
11. M. Buttini, A. Sauter, H. Boddeke, Induction of interleukin-1β mRNA after focal cerebral ischaemia in the rat, Mol. Brain Res. 23 (1994) 126-134.
12. D.B. Carter, M.R. Deibel, C.J. Dunn, C.-S. Tomich, A.L. Laborde, J.L. Slighton, A.E. Berger, M.J. Bienkowski, F.F. Sun, R.N. McEwan, P.K.W. Harris, A.W. Yem, G.A. Waszak, J.G. Chosay, L.C. Sieu, S.E. Truesdell, J.A. Shelly, T.E. Eessalu, B.M. Taylor, D.E. Tracey, Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein, Nature 344 (1990) 633-638.
13. P.J. Coffey, V.H. Perry, J.N.P. Rawlins, An investigation into the early stages of the inflammatory response following ibotenic acid-induced neuronal degeneration, Neuroscience 35 (1990) 121-132.
14. M.J. Dascombe, The pharmacology of fever, Prog. Neurobiol. 25 (1985) 327-373.
15. C.A. Dinarello, Biologic basis for interleukin-1 in disease, Blood 87 (1996) 2147-2195.
16. C.A. Dinarello, S.M. Wolff, The role of interleukin-1 in disease, New Engl. J. Med. 328 (1993) 106-113.
17. D.J. Dripps, B.J. Brandhuber, R.C. Thompson, S.P. Eisenberg, Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction, J. Biol. Chem. 266 (1991) 10331-10336.
18. S.P. Eisenberg, M.T. Brewer, E. Verderber, P. Heimdal, B.J. Brandhuber, R.C. Thompson, Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism, Proc. Natl Acad. Sci. 88 (1991) 5232-5236.
19. S.P. Eisenberg, R.J. Evans, W.P. Arend, E. Verderber, M.T. Brewer, C.H. Hannum, R.C. Thompson, Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist, Nature 343 (1990) 341-346.
20. A. Ericsson, C. Liu, R.P. Hart, P.E. Sawchenko, Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation, J. Comp. Neurol. 361 (1995) 681-698.
21. C. Eriksson, M. Schultzberg, Induction of interleukin-1 receptor antagonist mRNA in the rat brain after systemic administration of kainic acid, Soc. Neurosci. 23 (1997) 1511.
22. M. Ferretti, V. Casini-Raggi, T. Pizarro, S.P. Eisenberg, C.C. Nast, F. Cominelli, Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis, J. Clin. Invest. 94 (1994) 449-453.
23. E. Fischer, K.J. Van Zee, M.A. Marano, C.S. Rock, J.S. Kenney, D.D. Poutsiaka, C.A. Dinarello, S.F. Lowry, L.L. Moldawer, Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease, Blood 79 (1992) 2196-2200.
24. C. Gabay, M.F. Smith, D. Eidlen, W.P. Arend, Interleukin 1 receptor antagonist (IL-1ra) is an acute-phase protein, J. Clin. Invest. 99 (1997) 2930-2940.
25. J.H. Garcia, K.F. Liu, J.K. Relton, Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion, Am. J. Pathol. 147 (1995) 1477-1486.
26. S. Gatti, T. Bartfai, Induction of tumour necrosis factor-α mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6, Brain Res. 624 (1993) 291-294.
27. E.V. Granowitz, A.A. Santos, D.D. Poutsiaka, J.G. Cannon, D.W. Wilmore, S.M. Wolff, C.A. Dinarello, Production of interleukin-1 receptor antagonist during experimental endotoxaemia, Lancet 338 (1991) 1423-1424.
28. W.S.T. Griffin, L.C. Stanley, C. Ling, L. White, V. MacLeod, L.J. Perrot, C.L. White III, C. Araoz, Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease, Proc. Natl. Acad. Sci. 86 (1989) 7611-7615.
29. C.H. Hannum, C.J. Wilcox, W.P. Arend, F.G. Joslin, D.J. Dripps, P.L. Heimdal, L.G. Armes, A. Sommer, S.P. Eisenberg, R.C. Thompson, Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor, Nature 343 (1990) 336-340.
30. S. Haskill, G. Martin, L. Van Le, J. Morris, A. Peace, C.F. Bigler, G.J. Jaffe, C. Hammerberg, S.A. Sporn, S. Fong, W.P. Arend, P. Ralph, cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium, Proc. Natl Acad. Sci. 88 (1991) 3681-3685.
31. S. Holmin, M. Schalling, B. Höjeberg, A.-C. Sandberg Nordqvist, A.-K. Skeftruna, T. Mathiesen, Delayed cytokine expression in rat brain following experimental contusion, J. Neurosurg. 86 (1997) 493-504.
32. S.E. Ilyin, C.R. Plata-Salamán, In vivo regulation of the IL-1β system (ligand, receptors I and II, receptor accessory protein, and receptor antagonist) and TNF-α mRNAs in specific brain regions, Biochem. Biophys. Res. Commun. 227 (1996) 861-867.
33. K.L. Isaacs, R.B. Sartor, S. Haskill, Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification, Gastroenterology 103 (1992) 1587-1595.
34. M.B. Jørgensen, B.R. Finsen, M.B. Jensen, B. Castellano, N.H. Diemer, J. Zimmer, Microglial and astroglial reactions to ischemic and kainic acid-induced lesion of the adult rat hippocampus, Exp. Neurol. 120 (1993) 70-88.
35. H. Katsuki, S. Nakai, Y. Hirai, K.-I. Akaji, Y. Kiso, M. Satoh, Interleukin-1β inhibits long-term potentiation in the CA3 region of hippocampal slices, Eur. J. Pharmacol. 181 (1990) 323-326.
36. M. Kristensen, B. Deleuran, D.J. Eedy, Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin-1α in normal and psoriatic skin, Br. J. Dermatol. 127 (1992) 305-311.
37. J. Licinio, M.-L. Wong, P.W. Gold, Localization of interleukin-1 receptor antagonist mRNA in rat brain, Endocrinology 129 (1991) 562-564.
38. T. Liu, P.C. McDonnell, P.R. Young, R.F. White, A.L. Siren, J.M. Hallenbeck, F.C. Barone, G.Z. Feuerstein, Interleukin-1β mRNA expression in ischemic rat cortex, Stroke 24 (1993) 1746-1751.
39. S.A. Loddick, M.L. Wong, P.B. Bongiorno, P.W. Gold, J. Licinio, N.J. Rothwell, Endogenous interleukin-1 receptor antagonist is neuroprotective, Biochem. Biophys. Res. Commun. 234 (1997) 211-215.
40. F.W. Lothman, R.C. Collins, Kainic acid-induced limbic motor seizures: metabolic, behavioral electroencephalographic and neuropathological correlates, Brain Res. 218 (1981) 299-318.
41. J.D. Malone, M. Richards, A.J. Kahn, Human peripheral monocytes express putative receptors for neuroexcitatory amino acids, Proc. Natl Acad. Sci. 83 (1986) 3307-3310.
42. J. Martel-Pelletier, R. McCollum, J.P. Pelletier, The synthesis of IL-1 receptor antagonist (IL- 1ra) by synovial fibroblasts is markedly increased by the cytokines TNFα and IL-1, Biochim. Biophys. Acta 1175 (1993) 302-305.
43. D. Martin, N. Chinookoswong, G. Miller, The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia, Exp. Neurol. 130 (1994) 362-367.
44. S. Marty, I. Dusart, M. Peschanski, Glial changes following an excitotoxic lesion in the CNS: I. Microglia/macrophages, Neuroscience 45 (1991) 529-539.
45. M. Minami, Y. Kuraishi, M. Satoh, Effects of kainic acid on messenger RNA levels of IL-1β, IL-6, TNF-α and LIF in the rat brain, Biochem. Biophys. Res. Commun. 176 (1991) 593-598.
46. M. Minami, Y. Kuraishi, K. Yabuuchi, A. Yamazaki, M. Satoh, Induction of interleukin-1β mRNA in rat brain after transient forebrain ischemia, J. Neurochem. 58 (1992) 390-392.
47. M. Minami, Y. Kuraishi, T. Yamaguchi, S. Nakai, Y. Hirai, M. Satoh, Convulsants induce interleukin-1β messenger RNA in rat brain, Biochem. Biophys. Res. Commun. 171 (1990) 832-837.
48. T. Morioka, A.N. Kalehua, W.J. Streit, The microglial reaction in the rat dorsal hippocampus following transient forebrain ischemia, J. Cereb. Blood Flow Metab. 11 (1991) 966-973.
49. Y. Murabe, Y. Ibata, Y. Sano, Morphological studies on neuroglia: II. Response of glial cells to kainic acid-induced lesions, Cell Tissue Res. 216 (1981) 569-580.
50. M. Muzio, N. Polentarutti, M. Sironi, G. Poli, L. De Gioia, M. Introna, A. Mantovani, F. Colotta, Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist, J. Exp. Med. 182 (1995) 623-628.
51. M. Muzio, M. Sironi, N. Polentarutti, A. Mantovani, F. Colotta, Induction by transforming growth factor-β 1 of the interleukin-1 receptor antagonist and of its intracellular form in human polymorphonuclear cells, Eur. J. Immunol. 24 (1994) 3194-3198.
52. K. Ohlsson, P. Björk, M. Bergenfeldt, R. Hageman, R.C. Thompson, Interleukin-1 receptor antagonist reduces mortality from endotoxin shock, Nature 348 (1990) 550-552.
53. P.H. Patterson, Cytokines in Alzheimer's disease and multiple sclerosis, Curr. Opin. Neurobiol. 5 (1995) 642-646.
54. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1986.
55. I. Perez-Otano, N.K. McMillian, J. Chen, G.Y. Bing, J.S. Hong, K.R. Pennypacker, Induction of NF-κB-like transcription factors in brain areas susceptible to kainate toxicity, Glia 16 (1996) 306-315.
56. J.K. Relton, N.J. Rothwell, Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat, Brain Res. Bull. 29 (1992) 242-246.
57. C. Rivier, R. Chizzonite, W. Vale, In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1, Endocrinology 125 (1989) 2800-2805.
58. T.R. Sairanen, P.J. Lindsberg, M. Brenner, A.L. Sirén, Global forebrain ischemia results in differential cellular expression of interleukin-1β (IL-1β) and its receptor at mRNA and protein level, J. Cereb. Blood Flow Metab. 17 (1997) 1107-1120.
59. R. Sapolsky, C. Rivier, G. Yamamoto, P. Plotsky, W. Vale, Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor, Science 238 (1987) 522-524.
60. R. Schindler, B.D. Clark, C.A. Dinarello, Dissociation between interleukin-1β mRNA and protein synthesis in human peripheral blood mononuclear cells, J. Biol. Chem. 265 (1990) 10232-10237.
61. M. Schultzberg, S. Tingsborg, S. Nobel, J. Lundkvist, S. Svenson, A. Simoncsits, T. Bartfai, Interleukin-1 receptor antagonist protein and mRNA in the rat adrenal gland, J. Interferon Cytokine Res. 15 (1995) 723-731.
62. J.H. Schwab, S.K. Anderle, R.R. Broen, F.G. Dalldorf, Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats, Infect. Immun. 59 (1991) 4436-4442.
63. J.E. Schwob, T. Fuller, J.L. Price, J.W. Olney, Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study, Neuroscience 5 (1980) 991-1014.
64. G. Sperk, H. Lassmann, H. Baran, S.J. Kish, F. Seitelberger, Kainic acid induced seizures: neurochemical and histopathological changes, Neuroscience 10 (1983) 1301-1315.
65. J.T. Stitt, Neurophysiology of fever, Fed. Proc., Fed. Am. Soc. Exp. Biol. 40 (1981) 2835-2842.
66. H. Tilg, E. Vannier, G. Vachino, C.A. Dinarello, J.W. Mier, Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1β synthesis by human peripheral blood mononuclear cells, J. Exp. Med. 178 (1993) 1629-1636.
67. I. Tobler, A.A. Borbely, M. Schwyzer, A. Fontana, Interleukin-1 derived from astrocytes enhances slow-wave sleep activity in sleep EEG of the rat, Eur. J. Pharmacol. 104 (1984) 191.
68. T.R. Ulich, K. Guo, S. Yin, J. del Castillo, E. Yi, R.C. Thompson, S.P. Eisenberg, Endotoxin-induced cytokine gene expression in vivo: IV. Expression of interleukin-1 α/β and interleukin 1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation, Am. J. Pathol. 141 (1992) 61-68.
69. P. Vandenabeele, W. Fiers, Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?, Immunol. Today 12 (1991) 217-219.
70. X. Wang, F.C. Barone, N.V. Aiyar, G.Z. Feuerstein, Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats, Stroke 28 (1997) 155-162.
71. M.L. Wong, P.B. Bongiorno, P.W. Gold, J. Licinio, Localization of interleukin-1β converting enzyme mRNA in rat brain vasculature: evidence that the genes encoding the interleukin-1 system are constitutively expressed in brain blood vessels: pathophysiological implications, NeuroImmunoModulation 2 (1995) 141-148.
72. M.L. Wong, J. Licinio, Localization of interleukin-1 type I receptor mRNA in rat brain, NeuroImmunoModulation 1 (1994) 110-115.
73. M.N. Woodroofe, G.S. Sarna, M. Wadhwa, G.M. Hayes, A.J. Loughlin, A. Tinker, M.L. Cuzner, Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence for a role for microglia in cytokine production, J. Neuroimmunol. 33 (1991) 227-236.
74. K. Yabuuchi, M. Minami, S. Katsumata, M. Satoh, In situ hybridization study of interleukin-1β mRNA induced by kainic acid in the rat brain, Mol. Brain Res. 20 (1993) 153-161.
75. K. Yabuuchi, M. Minami, S. Katsumata, A. Yamazaki, M. Satoh, An in situ hybridization study on interleukin-1β mRNA induced by transient forebrain ischemia in the rat brain, Mol. Brain Res. 26 (1994) 135-142.
76. Y. Yamasaki, N. Matsuura, H. Shozuhara, H. Onodera, Y.K. Itoyama, Interleukin-1 as a pathogenetic mediator of ischemic brain damage in the rats, Stroke 26 (1995) 676-681.
77. G.-Y. Yang, Y.-J. Zhao, B.L. Davidson, A.L. Betz, Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury, Brain Res. 751 (1997) 181-188.
78. W.S. Young, III, In situ hybridization histochemistry, in: A. Björklund, T. Hökfelt, F.T. Wouterlood, A.N. van del Pol (Eds.), Handbook of Chemical Neuroanatomy, Vol. 8, Elsevier, New York, 1990, pp. 481-512.